| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0087 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |